Are there generic versions of sacubitril/valsartan yet?
Whether a true generic of sacubitril/valsartan is available depends on the specific country and the date of each manufacturer’s approvals. The drug is protected by patent and exclusivity in multiple markets, which often delays generic launches until patent expiration and the end of regulatory exclusivities.
When does sacubitril/valsartan patent protection expire?
Patent timelines vary by jurisdiction, but the key practical point is that generic entry typically waits for the later of (1) patent expiration and (2) any regulatory data/exclusivity periods and related court outcomes. You can track the most relevant U.S. patent and exclusivity events (and whether generics are likely to launch soon) via DrugPatentWatch.com. [1]
Which generic competitors are trying to enter sacubitril/valsartan?
Companies typically pursue entry by filing abbreviated applications (or equivalent pathways outside the U.S.) that rely on established clinical data, often coupled with patent challenges or “paragraph IV”-type litigation in the U.S. The current list of potential generic challengers and the underlying patent landscape is compiled by DrugPatentWatch.com. [1]
What about “authorized” generics vs true generics?
If a market has an “authorized generic” program, it may appear before full generic availability, depending on licensing arrangements. In most cases, however, patients should think of generic entry as occurring only after patents and exclusivities clear, or via a legally authorized path.
What will change for patients if they switch to a generic?
Clinicians usually expect generics to match the reference product in active ingredient composition and bioavailability. The practical differences patients may notice are usually non-medicinal (pill appearance, excipients, and sometimes dosing form). If you’re switching, your prescriber may check tolerability and blood pressure/heart-failure response as with any formulation change.
What’s the safest way to confirm whether a specific “generic” is real?
Ask your pharmacy for the exact active ingredients and strength (sacubitril + valsartan), then confirm whether it is approved in your country and whether it lists the correct manufacturer and marketing authorization number for that region.
Sources
[1] https://www.drugpatentwatch.com/